|
B Cell Receptor Signaling Pathway
|
98 |
|
Trans-sulfuration pathway
|
10 |
|
Nanoparticle triggered autophagic cell death
|
24 |
|
Benzene metabolism
|
6 |
|
Codeine and Morphine Metabolism
|
15 |
|
Calcium Regulation in the Cardiac Cell
|
151 |
|
miR-517 relationship with ARCN1 and USP1
|
5 |
|
Alanine and aspartate metabolism
|
12 |
|
White fat cell differentiation
|
33 |
|
EGF/EGFR Signaling Pathway
|
163 |
|
DNA Replication
|
42 |
|
Pyrimidine metabolism
|
86 |
|
Vitamin B12 Metabolism
|
53 |
|
Angiopoietin Like Protein 8 Regulatory Pathway
|
132 |
|
DNA Damage Response
|
69 |
|
Oxidative Damage
|
41 |
|
Spinal Cord Injury
|
119 |
|
Phase I biotransformations, non P450
|
8 |
|
Nicotine Activity on Dopaminergic Neurons
|
21 |
|
Benzo(a)pyrene metabolism
|
9 |
|
PI3K/AKT/mTOR - VitD3 Signalling
|
22 |
|
IL-1 signaling pathway
|
57 |
|
Gastric Cancer Network 1
|
29 |
|
Cytosine methylation
|
9 |
|
Copper homeostasis
|
54 |
|
Kit receptor signaling pathway
|
60 |
|
TGF-beta Receptor Signaling
|
58 |
|
Caffeine and Theobromine metabolism
|
4 |
|
Vitamin D Metabolism
|
10 |
|
Thyroxine (Thyroid Hormone) Production
|
6 |
|
Prostaglandin Synthesis and Regulation
|
45 |
|
FTO Obesity Variant Mechanism
|
8 |
|
Amyotrophic lateral sclerosis (ALS)
|
38 |
|
Serotonin Receptor 4/6/7 and NR3C Signaling
|
19 |
|
ID signaling pathway
|
16 |
|
Integrated Breast Cancer Pathway
|
154 |
|
Metastatic brain tumor
|
28 |
|
Type II interferon signaling (IFNG)
|
37 |
|
Development and heterogeneity of the ILC family
|
32 |
|
Mitochondrial LC-Fatty Acid Beta-Oxidation
|
17 |
|
Hematopoietic Stem Cell Differentiation
|
47 |
|
Methionine De Novo and Salvage Pathway
|
22 |
|
TP53 Network
|
20 |
|
GABA receptor Signaling
|
31 |
|
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition
|
18 |
|
Valproic acid pathway
|
13 |
|
Glial Cell Differentiation
|
8 |
|
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways
|
162 |
|
Histone Modifications
|
69 |
|
Pathways in clear cell renal cell carcinoma
|
87 |
|
miRNAs involved in DNA damage response
|
50 |
|
Zinc homeostasis
|
37 |
|
BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation
|
13 |
|
Alzheimers Disease
|
149 |
|
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway
|
47 |
|
Imatinib and Chronic Myeloid Leukemia
|
21 |
|
Eicosanoid Synthesis
|
23 |
|
Signaling of Hepatocyte Growth Factor Receptor
|
34 |
|
Signal Transduction of S1P Receptor
|
26 |
|
Selenium Micronutrient Network
|
88 |
|
Eukaryotic Transcription Initiation
|
42 |
|
Wnt Signaling Pathway and Pluripotency
|
106 |
|
Glutathione metabolism
|
22 |
|
NOTCH1 regulation of human endothelial cell calcification
|
18 |
|
Role of Osx and miRNAs in tooth development
|
36 |
|
Deregulation of Rab and Rab Effector Genes in Bladder Cancer
|
16 |
|
IL-5 Signaling Pathway
|
40 |
|
SRF and miRs in Smooth Muscle Differentiation and Proliferation
|
13 |
|
HIF1A and PPARG regulation of glycolysis
|
8 |
|
Sterol Regulatory Element-Binding Proteins (SREBP) signalling
|
73 |
|
Folate-Alcohol and Cancer Pathway Hypotheses
|
9 |
|
GPCRs, Class A Rhodopsin-like
|
258 |
|
Allograft Rejection
|
89 |
|
IL1 and megakaryocytes in obesity
|
25 |
|
Chemokine signaling pathway
|
165 |
|
MECP2 and Associated Rett Syndrome
|
62 |
|
Focal Adhesion
|
212 |
|
miRs in Muscle Cell Differentiation
|
36 |
|
Primary Focal Segmental Glomerulosclerosis FSGS
|
74 |
|
Glucuronidation
|
26 |
|
TarBasePathway
|
19 |
|
mRNA Processing
|
133 |
|
Wnt/beta-catenin Signaling Pathway in Leukemia
|
24 |
|
RalA downstream regulated genes
|
12 |
|
Interleukin-1 Induced Activation of NF-kappa-B
|
10 |
|
EBV LMP1 signaling
|
24 |
|
Farnesoid X Receptor Pathway
|
19 |
|
Nicotine Activity on Chromaffin Cells
|
4 |
|
mir-124 predicted interactions with cell cycle and differentiation
|
7 |
|
Hepatitis C and Hepatocellular Carcinoma
|
51 |
|
Transcription factor regulation in adipogenesis
|
22 |
|
Pentose Phosphate Pathway
|
7 |
|
miRNA Biogenesis
|
8 |
|
Electron Transport Chain
|
105 |
|
Melatonin metabolism and effects
|
42 |
|
Dual hijack model of Vif in HIV infection
|
8 |
|
AGE/RAGE pathway
|
66 |
|
miR-509-3p alteration of YAP1/ECM axis
|
19 |
|
Nucleotide GPCRs
|
11 |
|
Translation Factors
|
53 |
|
Estrogen metabolism
|
19 |
|
miRNA regulation of p53 pathway in prostate cancer
|
34 |
|
G Protein Signaling Pathways
|
95 |
|
Differentiation Pathway
|
48 |
|
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection
|
62 |
|
TFs Regulate miRNAs related to cardiac hypertrophy
|
12 |
|
TGF-beta Signaling Pathway
|
133 |
|
ATM Signaling Pathway
|
40 |
|
Toll-like Receptor Signaling Pathway
|
103 |
|
Interferon type I signaling pathways
|
55 |
|
Oxidative phosphorylation
|
62 |
|
Arylamine metabolism
|
6 |
|
Photodynamic therapy-induced AP-1 survival signaling.
|
51 |
|
NAD metabolism, sirtuins and aging
|
11 |
|
Fatty Acid Biosynthesis
|
22 |
|
Corticotropin-releasing hormone signaling pathway
|
93 |
|
GPCRs, Class C Metabotropic glutamate, pheromone
|
16 |
|
Amplification and Expansion of Oncogenic Pathways as Metastatic Traits
|
17 |
|
Exercise-induced Circadian Regulation
|
49 |
|
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities
|
30 |
|
LncRNA-mediated mechanisms of therapeutic resistance
|
12 |
|
Insulin signalling in human adipocytes (normal condition)
|
8 |
|
Neural Crest Differentiation
|
102 |
|
Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)
|
5 |
|
Apoptosis Modulation by HSP70
|
19 |
|
Serotonin Transporter Activity
|
11 |
|
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway
|
42 |
|
SCFA and skeletal muscle substrate metabolism
|
6 |
|
NRF2 pathway
|
144 |
|
RAC1/PAK1/p38/MMP2 Pathway
|
69 |
|
Synaptic Vesicle Pathway
|
52 |
|
Ovarian Infertility Genes
|
32 |
|
Metabolism of Spingolipids in ER and Golgi apparatus
|
8 |
|
TCA Cycle
|
17 |
|
Parkinsons Disease Pathway
|
84 |
|
Arrhythmogenic Right Ventricular Cardiomyopathy
|
76 |
|
MFAP5-mediated ovarian cancer cell motility and invasiveness
|
13 |
|
Type III interferon signaling
|
10 |
|
Peroxisomal beta-oxidation of tetracosanoyl-CoA
|
4 |
|
Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
|
88 |
|
Diclofenac Metabolic Pathway
|
4 |
|
Globo Sphingolipid Metabolism
|
22 |
|
Urea cycle and metabolism of amino groups
|
20 |
|
Non-homologous end joining
|
7 |
|
Heme Biosynthesis
|
9 |
|
One Carbon Metabolism
|
30 |
|
H19 action Rb-E2F1 signaling and CDK-β-catenin activity
|
16 |
|
Overview of nanoparticle effects
|
19 |
|
Glycolysis and Gluconeogenesis
|
23 |
|
Myometrial Relaxation and Contraction Pathways
|
158 |
|
Constitutive Androstane Receptor Pathway
|
32 |
|
Lung fibrosis
|
63 |
|
Simplified Depiction of MYD88 Distinct Input-Output Pathway
|
19 |
|
Nanomaterial induced apoptosis
|
21 |
|
Blood Clotting Cascade
|
23 |
|
Serotonin Receptor 2 and STAT3 Signaling
|
4 |
|
Insulin Signaling
|
161 |
|
Sulfation Biotransformation Reaction
|
18 |
|
Interactome of polycomb repressive complex 2 (PRC2)
|
17 |
|
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
|
20 |
|
Robo4 and VEGF Signaling Pathways Crosstalk
|
6 |
|
Nanoparticle triggered regulated necrosis
|
11 |
|
Nuclear Receptors in Lipid Metabolism and Toxicity
|
35 |
|
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)
|
16 |
|
DNA IR-damage and cellular response via ATR
|
80 |
|
Leptin signaling pathway
|
76 |
|
DNA Damage Response (only ATM dependent)
|
114 |
|
Methylation Pathways
|
10 |
|
NLR Proteins
|
9 |
|
Cytoplasmic Ribosomal Proteins
|
90 |
|
Estrogen Receptor Pathway
|
13 |
|
Gastric Cancer Network 2
|
33 |
|
Transcriptional activation by NRF2
|
15 |
|
IL-7 Signaling Pathway
|
25 |
|
Tryptophan metabolism
|
46 |
|
Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation
|
3 |
|
Gut-Liver Indole Metabolism
|
1 |
|
Sphingolipid Metabolism
|
25 |
|
Complement Activation
|
22 |
|
Alpha 6 Beta 4 signaling pathway
|
35 |
|
Colchicine Metabolic Pathway
|
1 |
|
Adipogenesis
|
131 |
|
ATR Signaling
|
9 |
|
TYROBP Causal Network
|
63 |
|
Glucocorticoid and Mineralcorticoid Metabolism
|
8 |
|
Serotonin and anxiety
|
17 |
|
Polyol Pathway
|
4 |
|
EV release from cardiac cells and their functional effects
|
9 |
|
Statin Pathway
|
33 |
|
Arachidonate Epoxygenase / Epoxide Hydrolase
|
7 |
|
Extracellular vesicle-mediated signaling in recipient cells
|
30 |
|
Leptin Insulin Overlap
|
17 |
|
ATM Signaling Network in Development and Disease
|
46 |
|
Bone Morphogenic Protein (BMP) Signalling and Regulation
|
12 |
|
Heroin metabolism
|
3 |
|
Regulation of Actin Cytoskeleton
|
150 |
|
Initiation of transcription and translation elongation at the HIV-1 LTR
|
37 |
|
Tumor suppressor activity of SMARCB1
|
33 |
|
Bladder Cancer
|
32 |
|
miRNA Regulation of DNA Damage Response
|
93 |
|
Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds
|
18 |
|
GPR40 Pathway
|
16 |
|
Development of pulmonary dendritic cells and macrophage subsets
|
13 |
|
Cell Differentiation - Index
|
38 |
|
Photodynamic therapy-induced NF-kB survival signaling
|
35 |
|
ESC Pluripotency Pathways
|
118 |
|
NO/cGMP/PKG mediated Neuroprotection
|
48 |
|
BDNF-TrkB Signaling
|
33 |
|
Regulation of Apoptosis by Parathyroid Hormone-related Protein
|
22 |
|
Hfe effect on hepcidin production
|
7 |
|
IL-2 Signaling Pathway
|
42 |
|
Insulin signalling in human adipocytes (diabetic condition)
|
8 |
|
Steroid Biosynthesis
|
10 |
|
Leptin and adiponectin
|
10 |
|
Notch Signaling Pathway
|
62 |
|
NAD+ metabolism
|
16 |
|
Prader-Willi and Angelman Syndrome
|
42 |
|
Structural Pathway of Interleukin 1 (IL-1)
|
50 |
|
Mitochondrial Gene Expression
|
20 |
|
Canonical and Non-canonical Notch signaling
|
27 |
|
Mesodermal Commitment Pathway
|
156 |
|
PPAR Alpha Pathway
|
26 |
|
PTF1A related regulatory pathway
|
11 |
|
Striated Muscle Contraction
|
38 |
|
ApoE and miR-146 in inflammation and atherosclerosis
|
9 |
|
Aflatoxin B1 metabolism
|
7 |
|
MAPK and NFkB Signalling Pathways Inhibited by Yersinia YopJ
|
12 |
|
PPAR signaling pathway
|
67 |
|
Selenium Metabolism and Selenoproteins
|
46 |
|
Vitamin A and Carotenoid Metabolism
|
44 |
|
PDGF Pathway
|
39 |
|
Angiogenesis
|
24 |
|
Liver X Receptor Pathway
|
10 |
|
EDA Signalling in Hair Follicle Development
|
13 |
|
Regulation of toll-like receptor signaling pathway
|
145 |
|
Amino acid conjugation of benzoic acid
|
4 |
|
IL17 signaling pathway
|
31 |
|
TLR4 Signaling and Tolerance
|
30 |
|
Oncostatin M Signaling Pathway
|
66 |
|
One carbon donor
|
1 |
|
ERK Pathway in Huntington's Disease
|
14 |
|
miRNA targets in ECM and membrane receptors
|
43 |
|
Regulation of Microtubule Cytoskeleton
|
49 |
|
Pregnane X Receptor pathway
|
33 |
|
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling
|
31 |
|
Amino Acid metabolism
|
91 |
|
Notch Signaling Pathway
|
46 |
|
Nanoparticle-mediated activation of receptor signaling
|
29 |
|
Toll-like Receptor Signaling
|
32 |
|
4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression
|
18 |
|
Ectoderm Differentiation
|
143 |
|
Physiological and Pathological Hypertrophy of the Heart
|
25 |
|
Integrin-mediated Cell Adhesion
|
104 |
|
RNA interference
|
7 |
|
Preimplantation Embryo
|
60 |
|
Dopaminergic Neurogenesis
|
30 |
|
Human Complement System
|
98 |
|
RIG-I-like Receptor Signaling
|
61 |
|
Monoamine GPCRs
|
33 |
|
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway
|
21 |
|
Oxytocin signaling
|
4 |
|
Synthesis and Degradation of Ketone Bodies
|
5 |
|
Metapathway biotransformation Phase I and II
|
177 |
|
White fat cell differentiation
|
33 |
|
Cell-type Dependent Selectivity of CCK2R Signaling
|
13 |
|
Energy Metabolism
|
48 |
|
Endoderm Differentiation
|
145 |
|
Glycerophospholipid Biosynthetic Pathway
|
21 |
|
Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex
|
22 |
|
MAPK Cascade
|
29 |
|
Glycogen Metabolism
|
36 |
|
Fatty Acid Beta Oxidation
|
34 |
|
MAPK Signaling Pathway
|
249 |
|
Felbamate Metabolism
|
2 |
|
DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM
|
55 |
|
Osteoblast Signaling
|
14 |
|
Butyrate-induced histone acetylation
|
2 |
|
Nicotine Metabolism
|
6 |
|
Prolactin Signaling Pathway
|
76 |
|
mir34a and TGIF2 in osteoclastogenesis
|
3 |
|
Osteopontin Signaling
|
13 |
|
Cori Cycle
|
16 |
|
Circadian rythm related genes
|
207 |
|
G13 Signaling Pathway
|
40 |
|
Biosynthesis and regeneration of tetrahydrobiopterin (BH4) and catabolism of phenylalanine, including diseases
|
4 |
|
Hypoxia-mediated EMT and Stemness
|
2 |
|
Tgif disruption of Shh signaling
|
9 |
|
Cholesterol Biosynthesis
|
15 |
|
Follicle Stimulating Hormone (FSH) signaling pathway
|
27 |
|
Heart Development
|
46 |
|
Irinotecan Pathway
|
13 |
|
Fluoropyrimidine Activity
|
34 |
|
Pathogenic Escherichia coli infection
|
55 |
|
Evolocumab Mechanism
|
3 |
|
Serotonin and anxiety-related events
|
13 |
|
Aryl Hydrocarbon Receptor Pathway
|
48 |
|
PDGFR-beta pathway
|
29 |
|
Folate Metabolism
|
69 |
|
Photodynamic therapy-induced unfolded protein response
|
29 |
|
Senescence and Autophagy in Cancer
|
106 |
|
Kennedy pathway from Sphingolipids
|
13 |
|
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
|
5 |
|
Dopamine metabolism
|
14 |
|
Endometrial cancer
|
63 |
|
BMP Signaling Pathway in Eyelid Development
|
20 |
|
MicroRNAs in cardiomyocyte hypertrophy
|
102 |
|
Secretion of Hydrochloric Acid in Parietal Cells
|
5 |
|
G1 to S cell cycle control
|
64 |
|
Integrated Cancer Pathway
|
46 |
|
Glucose Homeostasis
|
1 |
|
GPCRs, Other
|
94 |
|
AMP-activated Protein Kinase (AMPK) Signaling
|
68 |
|
Tamoxifen metabolism
|
21 |
|
T-Cell Receptor and Co-stimulatory Signaling
|
29 |
|
Hypothetical Craniofacial Development Pathway
|
8 |
|
Target Of Rapamycin (TOR) Signaling
|
37 |
|
Prion disease pathway
|
37 |
|
Signaling Pathways in Glioblastoma
|
83 |
|
Degradation pathway of sphingolipids, including diseases
|
3 |
|
Proteasome Degradation
|
64 |
|
Acetylcholine Synthesis
|
7 |
|
Inflammatory Response Pathway
|
33 |
|
Association Between Physico-Chemical Features and Toxicity Associated Pathways
|
68 |
|
GPCRs, Class B Secretin-like
|
24 |
|
IL-9 Signaling Pathway
|
19 |
|
Oxidative Stress
|
31 |
|
Endochondral Ossification
|
65 |
|
Gene regulatory network modelling somitogenesis
|
11 |
|
NAD Biosynthesis II (from tryptophan)
|
8 |
|
Complement and Coagulation Cascades
|
59 |
|
Cell Cycle
|
122 |
|
Endothelin Pathways
|
34 |
|
Matrix Metalloproteinases
|
30 |
|
Oxidation by Cytochrome P450
|
63 |
|
Apoptosis
|
86 |
|
Common Pathways Underlying Drug Addiction
|
42 |
|
IL-6 signaling pathway
|
43 |
|
Nuclear Receptors
|
39 |
|
Type II diabetes mellitus
|
22 |
|
p38 MAPK Signaling Pathway
|
34 |
|
Iron metabolism in placenta
|
12 |
|
miR-222 in Exercise-Induced Cardiac Growth
|
4 |
|
Aryl Hydrocarbon Receptor
|
48 |
|
TNF alpha Signaling Pathway
|
94 |
|
Nucleotide Metabolism
|
19 |
|
Apoptosis Modulation and Signaling
|
94 |
|
Influenza A virus infection
|
2 |
|
Differentiation of white and brown adipocyte
|
25 |
|
Drug Induction of Bile Acid Pathway
|
17 |
|
RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway
|
55 |
|
Mismatch repair
|
9 |
|
Wnt Signaling Pathway
|
117 |
|
miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma
|
9 |
|
Sulindac Metabolic Pathway
|
5 |
|
Estrogen signaling pathway
|
23 |
|
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation
|
44 |
|
Hypertrophy Model
|
20 |
|
Hedgehog Signaling Pathway
|
16 |
|
Cannabinoid receptor signaling
|
14 |
|
Lidocaine metabolism
|
2 |
|
Effects of Nitric Oxide
|
8 |
|
Retinoblastoma (RB) in Cancer
|
88 |
|
SREBF and miR33 in cholesterol and lipid homeostasis
|
19 |
|
ACE Inhibitor Pathway
|
17 |
|
Cardiac Progenitor Differentiation
|
53 |
|
Pathways Affected in Adenoid Cystic Carcinoma
|
66 |
|
miRNA regulation of prostate cancer signaling pathways
|
45 |
|
Human Thyroid Stimulating Hormone (TSH) signaling pathway
|
68 |
|
Cardiac Hypertrophic Response
|
57 |
|
Canonical and Non-Canonical TGF-B signaling
|
17 |
|
EPO Receptor Signaling
|
26 |
|
Apoptosis-related network due to altered Notch3 in ovarian cancer
|
54 |
|
eIF5A regulation in response to inhibition of the nuclear export system
|
4 |
|
DDX1 as a regulatory component of the Drosha microprocessor
|
9 |
|
Parkin-Ubiquitin Proteasomal System pathway
|
70 |
|
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway
|
144 |
|
Triacylglyceride Synthesis
|
26 |
|
Ebola Virus Pathway on Host
|
128 |
|
Osteoclast Signaling
|
16 |
|
Microglia Pathogen Phagocytosis Pathway
|
40 |
|
Peptide GPCRs
|
75 |
|
Composition of Lipid Particles
|
10 |
|
Nucleotide-binding Oligomerization Domain (NOD) pathway
|
41 |
|
Wnt Signaling in Kidney Disease
|
38 |
|
Androgen receptor signaling pathway
|
91 |
|
Mevalonate pathway
|
7 |
|
Cocaine metabolism
|
4 |
|
Splicing factor NOVA regulated synaptic proteins
|
42 |
|
NAD+ biosynthetic pathways
|
22 |
|
Biogenic Amine Synthesis
|
16 |
|
Hedgehog Signaling Pathway
|
44 |
|
Photodynamic therapy-induced HIF-1 survival signaling
|
37 |
|
Macrophage markers
|
9 |
|
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling
|
23 |
|
Trans-sulfuration and one carbon metabolism
|
32 |
|
Cytokines and Inflammatory Response
|
26 |
|
Homologous recombination
|
13 |
|
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease
|
25 |
|
Ethanol effects on histone modifications
|
31 |
|
ErbB Signaling Pathway
|
54 |
|
Interleukin-11 Signaling Pathway
|
44 |
|
Fatty Acid Omega Oxidation
|
15 |
|
Vitamin D Receptor Pathway
|
185 |
|
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway
|
309 |
|
IL-4 Signaling Pathway
|
55 |
|
Wnt Signaling Pathway
|
53 |
|
IL-3 Signaling Pathway
|
49 |
|
Cell Differentiation - Index expanded
|
48 |
|
Monoamine Transport
|
32 |
|
T-Cell antigen Receptor (TCR) Signaling Pathway
|
91 |
|
Gastric acid production
|
7 |
|
One carbon metabolism and related pathways
|
54 |
|
Small Ligand GPCRs
|
19 |
|
VEGFA-VEGFR2 Signaling Pathway
|
238 |
|
Ganglio Sphingolipid Metabolism
|
13 |
|
LncRNA involvement in canonical Wnt signaling and colorectal cancer
|
103 |
|
Pancreatic adenocarcinoma pathway
|
89 |
|
PI3K-Akt Signaling Pathway
|
345 |
|
Metabolism of Tetrahydrocannabinol (THC)
|
2 |
|
Non-small cell lung cancer
|
66 |
|
Breast cancer pathway
|
156 |
|
Somatroph axis (GH) and its relationship to dietary restriction and aging
|
6 |
|
Caloric restriction and aging
|
8 |
|
Fibrin Complement Receptor 3 Signaling Pathway
|
38 |
|
Hormonal control of Pubertal Growth Spurt
|
2 |
|
The human immune response to tuberculosis
|
22 |
|
MET in type 1 papillary renal cell carcinoma
|
59 |
|
Hereditary leiomyomatosis and renal cell carcinoma pathway
|
20 |
|
Tryptophan catabolism leading to NAD+ production
|
16 |
|
Transcriptional cascade regulating adipogenesis
|
13 |
|
Chromosomal and microsatellite instability in colorectal cancer
|
74 |
|
Neurotransmitter Disorders
|
5 |
|
Lipid Metabolism Pathway
|
29 |
|
Phosphodiesterases in neuronal function
|
53 |
|
Ras Signaling
|
185 |
|
Pyrimidine metabolism
|
9 |
|
Purine metabolism
|
14 |
|
Vitamin B6-dependent and responsive disorders
|
5 |
|
Acrylamide Biotransformation and Exposure Biomarkers
|
1 |
|
EMT in colorectal cancer
|
162 |
|
Type 2 papillary renal cell carcinoma
|
36 |
|
Regulation of sister chromatid separation at the metaphase-anaphase transition
|
16 |
|
Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer
|
5 |